Sanofi profit narrowly beats forecasts, sees stronger earnings growth in 2023

[ad_1] Sanofi SA on Friday posted rising earnings and sales for the fourth quarter and said it expects its earnings per share to grow in 2023. The French pharma major SAN, -2.18% SNY, -3.10% reported net profit of 1.46 billion euros ($1.59 billion) for the quarter, up from EUR1.13 billion in the same quarter of … Read more

Sanofi Non-GAAP EPS of €1.71 in-line, revenue of €10.72B misses by €260M; initiates FY23

[ad_1] Full-year 2023 business EPS guidance: Sanofi expects 2023 business EPS to grow low single digit at CER, barring unforeseen major adverse events. Applying average January 2023 exchange rates, the currency impact on 2023 business EPS is estimated between -3.5% to -4.5%. [ad_2] Source link